AT324883T
Pharmaceutical compostion comprising lumiracoxib
Abstract
The invention relates to a composition for the treatment of cyclooxygenase-2 mediated diseases and for the treatment of cyclooxygenase-2 mediated diseases. The composition according to the invention comprises about 65% by weight of 5-methyl-2- (2'-chloro-6'-fluoroanilino) phenylacetic acid or salt, and as excipients, polyvinylpyrrolidone, croscarmellose sodium, magnesium stearate and microcrystalline cellulose. Treatment is given daily with an immediate release tablet containing approximately 400 mg of active ingredient. Adherence is oral. HE
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
113 members in 30 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 31638901 | United States of America | P |
Members113
| Document | Office | Kind | |
|---|---|---|---|
| CA2425112A1 | Canada | A1 | |
| WO0229003A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU9664501A | Australia | A | |
| WO0229003A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002102586A1 | United States of America | A1 | |
| CA2456604A1 | Canada | A1 | |
| WO03020261A1 | World Intellectual Property Organization (WIPO) | A1 | |
| PE20030323A1 | Peru | A1 | |
| US2003114527A1 | United States of America | A1 | |
| EP1337541A2 | European Patent Office (EPO) | A2 | |
| US6664079B2 | United States of America | B2 | |
| JP2004510433A | Japan | A | |
| KR20040031019A | Republic of Korea | A | |
| NO20040860L | Norway | L | |
| ECSP044986A | Ecuador | A | |
| EP1425005A1 | European Patent Office (EPO) | A1 | |
| MXPA04001933A | Mexico | A | |
| BR0212155A | Brazil | A | |
| EP1337541A4 | European Patent Office (EPO) | A4 | |
| IL160375A0 | Israel | A0 | |
| IL160375D0 | Israel | D0 | |
| AR036312A1 | Argentina | A1 | |
| US2004185466A1 | United States of America | A1 | |
| ZA200400877B | South Africa | B | |
| HU0401429A2 | Hungary | A2 | |
| HUP0401429A2 | Hungary | A2 | |
| PL367464A1 | Poland | A1 | |
| RU2004109920A | Russian Federation | A | |
| JP2005520785A | Japan | A | |
| CO5560554A2 | Colombia | A2 | |
| NZ531342A | New Zealand | A | |
| CN1728993A | China | A | |
| EP1425005B1 | European Patent Office (EPO) | B1 | |
| DE60211183D1 | Germany | D1 | |
| AT324883TThis record | Austria | T | |
| ATE324883T1 | Austria | T1 | |
| AU2002331094B2 | Australia | B2 | |
| DK1425005T3 | Denmark | T3 | |
| PT1425005E | Portugal | E | |
| HK1087336A | Hong Kong, China | A | |
| HK1087336A1 | Hong Kong, China | A1 | |
| ES2263813T3 | Spain | T3 | |
| SI1425005T1 | Slovenia | T1 | |
| DE60211183T2 | Germany | T2 | |
| EP1337541B1 | European Patent Office (EPO) | B1 | |
| AT356222T | Austria | T | |
| ATE356222T1 | Austria | T1 | |
| DE60127162D1 | Germany | D1 | |
| EP1790736A2 | European Patent Office (EPO) | A2 | |
| DE20122767U1 | Germany | U1 | |
| EP1790736A3 | European Patent Office (EPO) | A3 | |
| US2007231382A1 | United States of America | A1 | |
| US7345159B2 | United States of America | B2 | |
| DE60127162T2 | Germany | T2 | |
| US2008131895A1 | United States of America | A1 | |
| RU2329801C2 | Russian Federation | C2 | |
| CN100406008C | China | C | |
| US2008199868A1 | United States of America | A1 | |
| US2008319179A1 | United States of America | A1 | |
| MY137516A | Malaysia | A | |
| KR100895551B1 | Republic of Korea | B1 | |
| US7635578B2 | United States of America | B2 | |
| US7713698B2 | United States of America | B2 | |
| US7790869B2 | United States of America | B2 | |
| US2010317012A1 | United States of America | A1 | |
| CA2456604C | Canada | C | |
| JP4636796B2 | Japan | B2 | |
| CY1106137T1 | Cyprus | T1 | |
| CA2425112C | Canada | C | |
| US8088575B2 | United States of America | B2 | |
| US2012142006A1 | United States of America | A1 | |
| US2013096015A1 | United States of America | A1 | |
| US2014206553A1 | United States of America | A1 | |
| US2015197800A1 | United States of America | A1 | |
| US9133511B2 | United States of America | B2 | |
| EP3034627A1 | European Patent Office (EPO) | A1 | |
| US2016264612A1 | United States of America | A1 | |
| US2017088574A1 | United States of America | A1 | |
| US2017088575A1 | United States of America | A1 | |
| US2017088891A1 | United States of America | A1 | |
| US2017190730A2 | United States of America | A2 | |
| US9708358B2 | United States of America | B2 | |
| US9718852B2 | United States of America | B2 | |
| US9719139B2 | United States of America | B2 | |
| US9725480B2 | United States of America | B2 | |
| HK1227441A | Hong Kong, China | A | |
| HK1227441A1 | Hong Kong, China | A1 | |
| US2017313737A1 | United States of America | A1 | |
| US9868985B2 | United States of America | B2 | |
| US2018201642A1 | United States of America | A1 | |
| EP3034627B1 | European Patent Office (EPO) | B1 | |
| US2019031704A1 | United States of America | A1 | |
| US2019031705A1 | United States of America | A1 | |
| US2019031706A1 | United States of America | A1 | |
| US2019085014A1 | United States of America | A1 | |
| US2019085015A1 | United States of America | A1 | |
| US2019085016A1 | United States of America | A1 | |
| US2019092805A1 | United States of America | A1 | |
| US2019092806A1 | United States of America | A1 | |
| US2019135850A1 | United States of America | A1 |
Showing 100 of 113
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP | |
| Change in the person of patent ownerEEIH | EEIH |
Numbers
- Application
- 2767455
Titles2
- German
- PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND LUMIRACOXIB
- English
- PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIBLE
Classification
- CPC, 3
- A61K31/196
- A61P29/00
- A61P43/00
- IPC, 13
- A61K9 20
- A61K
- A61K9 22
- A61K31 195
- A61K31 196
- A61K47 12
- A61K47 32
- A61K47 36
- A61K47 38
- A61P
- A61P29 00
- A61P43 00
- C07C